Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
19,807,471
-
Total 13F shares
-
6,655,293
-
Share change
-
-49,496
-
Total reported value
-
$70,535,482
-
Price per share
-
$10.58
-
Number of holders
-
27
-
Value change
-
-$511,206
-
Number of buys
-
5
-
Number of sells
-
8
Institutional Holders of Oaktree Acquisition Corp. III Life Sciences - COMMON-STOCK (OACC) as of Q4 2025
As of 31 Dec 2025,
Oaktree Acquisition Corp. III Life Sciences - COMMON-STOCK (OACC) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,655,293 shares.
The largest 10 holders included
AQR Arbitrage LLC, Empyrean Capital Partners, LP, D. E. Shaw & Co., Inc., Boussard & Gavaudan Investment Management LLP, Decagon Asset Management LLP, TORONTO DOMINION BANK, Driehaus Capital Management LLC, HighTower Advisors, LLC, Linden Advisors LP, and Sculptor Capital LP.
This page lists
49
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.